tipo
- journal article
Additional points to consider before incorporating the Food and Drug Administration-approved therapies for systemic sclerosis-associated interstitial lung disease
Documento
- Visão geral
- Pesquisas
- Identidade
- Informação adicional documento
- Outro
- Ver todos